ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,519.62
      1.53%
      US Tech 100
      18,770.00
      2.56%
      Dow Jones
      40,849.75
      0.26%
      Brent Oil
      80.405
      2.34%
      Bitcoin
      66,059.40
      -0.17%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Brazil
      5. BOV

      6. Healthpeak OP LLC (P1EA34R) Quote

      Healthpeak OP LLC

      Healthpeak OP LLC (P1EA34R)

      BOV
      117.48
      0.00
      ( 0.00% )
      Updated: 07:00:08
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      117.48
      Bid
      0.00
      Ask
      0.00
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Previous Close
      117.48
      Open
      -
      Last Trade
      Last Trade Time
      -
      Average Volume (3m)
      -
      Financial Volume
      -
      VWAP
      -

      P1EA34R Latest News

      More News

      Oxurion Share Consolidation

      Oxurion Share Consolidation Oxurion Share Consolidation Leuven, BELGIUM – July 25, 2024 – 06:00 PM CET Oxurion NV (Euronext Brussels: OXUR) (the Company), a biopharmaceutical company based in...

      July 25 2024
      UK Regulatory

      Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024

      Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024 Oxurion Announces Results on the Extraordinary General Meeting (EGM) of 24 July 2024 Leuven, BELGIUM – 24 July...

      July 24 2024
      UK Regulatory

      Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

      Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Information on the Total Number of Voting Rights (Denominator) following Conversion Notice...

      July 19 2024
      UK Regulatory

      Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

      Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – July 18, 2024 –...

      July 18 2024
      UK Regulatory

      Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024

      Oxurion provides clarification on the agenda of the extraordinary general shareholders' meeting to be held on 24 July 2024 Oxurion provides clarification on the agenda of the extraordinary...

      July 11 2024
      UK Regulatory

      Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production

      Oxurion signs a Letter of Intent and enters into exclusive negotiations to potentially acquire a pioneering French CRO in stem cell production Oxurion signs a Letter of Intent and enters into...

      July 08 2024
      UK Regulatory

      Oxurion announces the results of the Extraordinary General Meeting (EGM) held on 4 July 2024 and convenes a new EGM on 24 July 2024

      Oxurion announces the results of the Extraordinary General Meeting (EGM) held on 4 July 2024 and convenes a new EGM on 24 July 2024 Oxurion announces the results of the Extraordinary General...

      July 04 2024
      GlobeNewswire Inc.

      Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

      Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Leuven, BELGIUM – June 7, 2024...

      June 07 2024
      GlobeNewswire Inc.

      Oxurion Announces Extraordinary General Shareholders’ Meeting

      Oxurion Announces Extraordinary General Shareholders’ Meeting Oxurion Announces Extraordinary General Shareholders’ Meeting Leuven, BELGIUM – June 4, 2024 – 07:00 PM CET – Oxurion NV...

      June 04 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DR
      40000000DR
      120000000DR
      260000000DR
      520000000DR
      1560000000DR
      2600000000DR

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      IFCM11Infracommerce Caxaas S.A.
      R$ 0.06
      (20.00%)
      		16.5k
      NORD3Nordon Inds Metalurgicas Sa
      R$ 9.99
      (16.16%)
      		900
      WEGE3Weg Sa
      R$ 49.11
      (7.06%)
      		5.26M
      EALT4Electro Aco Altona Sa
      R$ 12.09
      (6.99%)
      		30.6k
      EALT3Electro Aco Altona Sa
      R$ 12.80
      (6.67%)
      		100
      FRIO3Metalfrio Solutions Sa
      R$ 165.00
      (-36.54%)
      		2.8k
      MAPT3Cemepe Invests Sa
      R$ 4.20
      (-8.70%)
      		200
      CSRN3Cia Energetica Rio Grande Norte Cosern
      R$ 15.90
      (-5.07%)
      		4.3k
      AMER3Americanas SA
      R$ 0.58
      (-4.92%)
      		21.65M
      BMIN4Bco Mercantil Invests Sa
      R$ 16.00
      (-3.79%)
      		100
      AMER3Americanas SA
      R$ 0.58
      (-4.92%)
      		21.65M
      ABEV3Ambev SA
      R$ 11.53
      (-0.86%)
      		13M
      HAPV3Hapvida Participacoes Investimento SA
      R$ 4.19
      (1.95%)
      		10.05M
      CIEL3Cielo SA
      R$ 5.76
      (0.17%)
      		9.24M
      COGN3CognaEducacao SA
      R$ 1.53
      (1.32%)
      		8.1M

      Discussion

      View Full Feed
      Triple nickle Triple nickle 3 minutes ago
      Not to shabby a spike
      NCNC
      88TH MAN 88TH MAN 4 minutes ago
      I have always been committed. I am "All In". I am holding!
      FBEC
      ProLiberty ProLiberty 4 minutes ago
      Next up is Italy... both approval and reimbursement expected / possible before year end.
      AMRN
      peafunke peafunke 4 minutes ago
      Let’s go Jake …


      When is the ride ?
      TPTW
      bob4uall bob4uall 4 minutes ago
      Edward, is your Board broken this morning? I’m not seeing my reply.
      BZWR
      SkeBallLarry SkeBallLarry 4 minutes ago
      " Am passing that on, CT ~ guess I missed it " .. !!
      bunda bunda 4 minutes ago
      you mama got kick by finra fuc-er
      IGPK
      John Doe 2024 John Doe 2024 4 minutes ago
      That will never happen.
      XERI
      Hercules1 Hercules1 4 minutes ago
      this is not closing under .004 today.


      next station is .005.
      HIRU
      ExtremelyBullishZig ExtremelyBullishZig 4 minutes ago
      Actually, they have been pointing it out for years since the beginning as the stat to watch .Maybe you should have been paying attention during the P2a.
      AVXL
      chonrm chonrm 4 minutes ago
      Loser Leslie killed this with incompetence. What do you expect with that stupid looking snake oil salesman mustache.
      INQD
      ducci1 ducci1 4 minutes ago
      Ridin 554C ,56 on 1st Vix By Sig ---think out at R2 !
      SPY
      work-n-hard work-n-hard 4 minutes ago
      Woops. lol
      SGMO
      jimmybob jimmybob 4 minutes ago
      $FVRR callllssssss
      FVRR
      Savannah-Marc Savannah-Marc 4 minutes ago
      Last call to own shares before the Tobique deal approves, last call.
      RONN
      redspinelpinktopaz redspinelpinktopaz 5 minutes ago
      Can't buy shares, with news about to be released.
      LWLG
      Carjockey2 Carjockey2 5 minutes ago
      "GARD" is a Buy Signal remember same thing at .0022
      HIRU
      surfer44 surfer44 5 minutes ago
      It looks like it may be similar to this book.

      https://youtu.be/4N3YIcFsHy4
      ExtremelyBullishZig ExtremelyBullishZig 5 minutes ago
      Safety record schmafety record...you are missing the point. You are missing the main point. Water is safe too...it doesn't fix AD...the approved drugs have proven to slow the decline in large populations...so they get the approval.

      If people including our CEO would follow rules, we wo
      AVXL
      Hosai Hosai 5 minutes ago
      Yes all true but I would remind that 24% of placebo patients didn't finish trial either.
      In a sense the 2:1 drug ratio perhaps helped in this context of things that it means with the smaller trial and drop outs there was still more data for patients on drug than if it had been 1:1.
      In
      AVXL
      Starlost Starlost 5 minutes ago
      https://twitter.com/CoinCitadelCCTL/status/1818469175951610029
      CCTL
      Itchy palm Itchy palm 5 minutes ago
      Sounds like a Steve Bannon line fascist piece of 💩
      LandPro LandPro 5 minutes ago
      Always good to see a new cheerleader show up,LOL... won't help.
      BLLB
      janetcanada janetcanada 6 minutes ago
      Good morning Sylvia, ***I Believe that Life Has a Way to "Teach Us Lesson"!.....

      And YES I agree that Sooner or Later what Goes Around come Around!......

      Wishing a Good Day

      Take Care
      janet
      GRST

      Your Recent History

      BOV
      P1EA34R
      Healthpeak OP
      BIT
      UC266U
      Unicredit Bank
      BIT
      P20L31
      NLBNPIT20L31 20991231 39...
      NYSE
      CPN
      Calpine
      Delayed Upgrade Clock